FcR Therapeutics | Valuation, Funding Rounds & Stock Price | Caplight
FcR Therapeutics
Private
Utrecht
Healthcare & Life Sciences
Website
Last Round: Seed
Date: Feb 4, 2025
Company Overview
FcR Therapeutics is a biotechnology company that develops recombinant nanobody-based therapeutics to modulate Fc receptor activity for the treatment of autoimmune diseases.
- Sector: Healthcare & Life Sciences
- Verticals: Biotechnology, Drug Discovery
- Business Model: B2B
- Customer Profile: Services & Consulting
- AI Layer: Non-AI
Keywords: nanobody therapeutics, recombinant nanobodies, autoimmune disease treatment, biotech drug discovery, Fc receptor modulation, biologics, immunology, drug development pipeline, biopharmaceutical R&D, therapeutic proteins, next-gen biologics, autoimmune research, single domain antibodies
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Unlock Pricing Charts
Caplight Momentum Score
Proprietary index based on bid/ask volume and sentiment.
View Momentum History
FcR Therapeutics Comparables
Compare FcR Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Kaigene Inc. | 79% | Unlock |
| Nuvig Therapeutics | 78% | Unlock |
| Cerberus Therapeutics | 77% | Unlock |
| Comparable company | 50% | Unlock |
FcR Therapeutics Funding Rounds
Historical fundraising activity.
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Feb 4, 2025 | Unlock | Unlock | Unlock | Unlock |
Key People
Founding team and executive leadership.
- Geert van Tetering
Chief Scientific Officer, Founder & Chief Operating Officer
LinkedIn profile - Guido Maertens
CEO and co-founder FcR Therapeutics
LinkedIn profile
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 3, 2026
Monthly visitors increased 168% MoM, reaching 260.
FcR Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
| Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about FcR Therapeutics's valuation, stock price, and market status.
- Is FcR Therapeutics a public or private company?
- What is the current stock price of FcR Therapeutics?
- How much is FcR Therapeutics worth (valuation)?
- Can I buy FcR Therapeutics stock?
- When was FcR Therapeutics's last funding round?
- Who are the main investors in FcR Therapeutics?
- Will FcR Therapeutics IPO soon?
- How can I track FcR Therapeutics secondary market activity?
Firmographic Details
- Headquarters: Utrecht
- Employee Range: 4
- Year Founded: 2025
- Last Funding: Feb 4, 2025